The effects of astemizole on histamine-induced weal and flare

Abstract
The effect of astemizole on the weal and flare response to intradermal histamine has been studied in normal volunteers after single dosing, and in patients with urticaria and pruritus after chronic dosing with the drug. Single doses of astemizole (40 mg) in normal volunteers significantly reduced histamine weal and flare at 24 and 48 h (pppppp1 antagonist activity.

This publication has 3 references indexed in Scilit: